Regeneron Pharmaceuticals Inc on Tuesday said its experimental twoantibody cocktail reduced viral levels and improved symptoms in nonhospitalized COVID19 patients, enhancing its chances of becoming a treatment for the disease that has killed over a million people worldwide.from Top Business News- News18.com
via IFTTT
No comments:
Post a Comment